Bristol-Myers to buy heart drugs developer MyoKardia for about $13 billion – CNBC

Bristol-Myers Squibb said on Monday it would buy MyoKardia for about $13 billion to bolster its portfolio of heart disease treatments, as it seeks to reduce some of its dependence on cancer drugs.
T… [read more]

Leave a Reply